These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1499627)

  • 1. Treatment of advanced bladder cancer by submucosal injection of methotrexate in the anorectal area.
    Damyanov C; Tonchev Z; Pavlova N; Ivanov A
    Eur Urol; 1992; 21(3):211-5. PubMed ID: 1499627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anal submucosal injection: a new route for drug administration in pelvic malignancies. II. Methotrexate anal injection in the treatment of advanced bladder cancer. Preliminary study.
    Shafik A; Haddad S; Elwan F; el-Metnawi W; Olfat E
    J Urol; 1988 Sep; 140(3):501-5. PubMed ID: 3045340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical studies on anal submucosal injection of methotrexate for bladder cancer].
    Yoshida T; Ogawa T; Fujinaga T; Kyoku I
    Hinyokika Kiyo; 1991 Aug; 37(8):857-61. PubMed ID: 1957728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder?
    Zincke H; Sen SE; Hahn RG; Keating JP
    Mayo Clin Proc; 1988 Jan; 63(1):16-22. PubMed ID: 3336237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder.
    Roberts JT; Fossa SD; Richards B; Kaye SB; White EF; Robinson MC; Uscinska B; Parmar MK
    Br J Urol; 1991 Aug; 68(2):162-8. PubMed ID: 1884143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
    Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal transitional cell carcinoma of bladder in renal transplant recipient.
    Thomalla JV; Leapman SB; Filo RS
    Urology; 1991 Dec; 38(6):567-70. PubMed ID: 1746091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment for advanced bladder cancer.
    Hall RR; Bloom HJ; Freeman JE; Nawrocki A; Wallace DM
    Br J Urol; 1974 Aug; 46(4):431-8. PubMed ID: 4414661
    [No Abstract]   [Full Text] [Related]  

  • 10. M-VAC versus CisCA--chemotherapy in the treatment of advanced bladder cancer.
    Heimbach D; Wirth M; Frohmüller H
    Urol Int; 1992; 48(2):157-61. PubMed ID: 1585511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
    Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
    de la Rosa F; Garcia-Carbonero R; Passas J; Rosino A; Lianes P; Paz-Ares L
    J Urol; 2002 Jun; 167(6):2413-8. PubMed ID: 11992048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate: an active drug in bladder cancer.
    Natale RB; Yagoda A; Watson RC; Whitmore WF; Blumenreich M; Braun DW
    Cancer; 1981 Mar; 47(6):1246-50. PubMed ID: 6971700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nb rat transitional cell bladder carcinoma model: dose response to methotrexate and adriamycin.
    Drago JR; Nesbitt JA
    Anticancer Res; 1986; 6(5):1019-20. PubMed ID: 3800312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B; Torelli T; Leidi GL; Corrada P; Bacchioni AM; Ordesi G; Zanitzer L
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anal submucosal injection: a new route for drug administration in pelvic malignancies. IV. Submucosal anal injection in the treatment of cancer of uterine cervix--preliminary study.
    Shafik A
    Am J Obstet Gynecol; 1989 Jul; 161(1):69-72. PubMed ID: 2750823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral methotrexate for superficial transitional cell carcinoma of the bladder.
    Olver IN; Sandeman TF; Laidlaw CR; Zimet AS; Bishop JF
    J Urol; 1993 May; 149(5):1006-9. PubMed ID: 8483200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder.
    Stoter G; Splinter TA; Child JA; Fosså SD; Denis L; van Oosterom AT; de Pauw M; Sylvester R
    J Urol; 1987 Apr; 137(4):663-7. PubMed ID: 3560318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).
    Fosså SD; Harland SJ; Kaye SB; Raghavan D; Russell JM; Parmar MK; Uscinska BM; Wood R
    Br J Urol; 1992 Aug; 70(2):161-8. PubMed ID: 1393439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for superficial bladder cancer.
    Hall RR
    Prog Clin Biol Res; 1985; 185B():143-9. PubMed ID: 3898139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.